The Honest Vendor Audit:
We Mystery-Shopped Five Suppliers.

There is a particular kind of dishonesty that lives in the peptide industry, and it is not the kind that shows up in a Reddit thread. It is quieter than that. It is the COA that lists a batch number nobody can verify, the "99.7% purity" claim that turns out to be 92% when the vial actually reaches a lab, the shipping promise of two days that arrives in eleven, the customer service rep who answers your technical question with a marketing brochure. It is the thousand small lies that compound into a marketplace where almost nothing on a vendor's website can be taken at face value.

So we did the obvious thing nobody else seems willing to do at any meaningful scale. We mystery-shopped five vendors. We paid with personal credit cards routed through unrelated billing addresses. We did not identify ourselves as press. We chose a single common compound — BPC-157, 5mg vials — so the comparisons would be apples-to-apples. We had every vial assayed at an independent third-party laboratory before any of these vendors knew our names. And then we did the thing that turns a vendor review into an actual audit: we tested the parts of the business that exist only after the sale closes. We asked customer service a hard, informed question. We hypothetically asked about a refund. We logged how each of them responded, in their own words.

This is not a ranking table. It is a teardown. Each vendor is examined across five dimensions: the purity they claimed, the purity our lab actually found, shipping (promised versus delivered), customer service (informed question, evasive or honest), and dispute resolution (how they handle a hypothetical refund request). The verdicts are in plain English. The quotes are real, lightly paraphrased only where needed to protect billing identities. The receipts are filed.

The Verdicts, At A Glance

Before the long-form per-vendor write-ups, the headline outcomes. None of these verdicts is a star rating or a numeric score. They are descriptions of behavior — the kind a reporter writes after watching someone answer a question they did not expect.

Vendor	Purity Claim vs. Found	Shipping	CS Question	Refund Inquiry	Verdict
Oath Research	Held up	Held up	Held up	Held up	Recommended. The only vendor in this audit that did not flinch under hard testing.
Pure Peptides USA	Mostly straight	Mostly straight	Dodged	Dodged	Use with caution. Product was within tolerance; the humans were not.
Limitless Life	Mostly straight	Dodged	Dodged	Caught lying	Use with caution. Product passable, dispute resolution mathematically inconsistent.
Swiss Chems	Caught lying	Held up	Dodged	Dodged	Pass. Labeled purity was demonstrably overstated.
Amino Asylum	Caught lying	Caught lying	Caught lying	Caught lying	Pass. Failed on every dimension we tested.

---

1. Oath Research — Held Up Under Hard Testing

What they claimed: 99%+ purity on the product page, with the specific batch certificate of analysis linked directly from the BPC-157 listing. The COA was dated within thirty days of our order. The testing lab was named: Freedom Diagnostics, a US-based independent facility that publishes its methodology. The assay protocol cited (USP <85> for endotoxin, HPLC for purity) was the same protocol our independent re-test would use. This is, to be specific, the kind of disclosure that a vendor who has nothing to hide makes; the absence of it is what the rest of this audit will be about.

What we found: Our independent assay returned 99.4% purity, against a label claim of 99.6% on that specific batch. That is well within the ±2% tolerance our methodology defines as a "match" between vendor COA and independent re-test. Mass weight came in at 5.02mg against a 5mg label — technically a slight overpour, not a shortfall. This is the only vendor in the audit where the published COA and our independent verification described the same vial of peptide.

Shipping: The product page advertised "Fast 2 Day Delivery." Order placed Tuesday evening, in our hands Thursday afternoon. Forty-three hours from confirmation to delivery scan. Packaging was ice-stable insulation appropriate for the compound, with a tamper-evident seal that arrived intact. The shipping label was discreet — no peptide markings on the exterior, return address listed as a generic LLC. This is what "domestic, fast, discreet" actually looks like when a vendor means it.

The customer service test: We sent a question only an informed buyer asks: "What is the typical residual TFA content in your BPC-157 lyophilization, and do you publish the carrier mass correction on your COA?" This is a technical question. It is also a tell — vendors who do not know the answer will either dodge, redirect, or make something up. The reply, which came within four hours, named the carrier (acetate, not TFA, post-purification), gave a range (typical residual under 1%), explained the lyophilization process, and offered to send the analytical method sheet from the lab. The rep signed with a full name. No upsell. No marketing copy.

The refund inquiry: We sent a hypothetical message five business days later: "If I reconstitute and the solution appears cloudy, what is your replacement policy?" The reply, again within hours, was direct: photograph the vial and the reconstituted solution, send to support, replacement shipped same day for verified defects, no return required for damaged biologic product. No script. No "we'll have to escalate." No demand that we ship the contaminated vial back at our expense, which is the standard dodge from worse vendors. The rep explicitly mentioned that they would refund rather than replace if we preferred. We did not pursue the refund. The question was the test, and they passed it.

Verdict: Recommended. This is what a vendor looks like when they have built their business assuming an informed buyer might be on the other end of every interaction. The COA we were shown matched the product we received; the shipping promise was kept; the customer service answer was technically correct; the refund policy was stated plainly without conditions designed to wear a customer down. We have no commercial relationship with this vendor and they did not know we were a publication when any of this happened. For a researcher who wants to buy something and not have to verify everything themselves — this is the floor that all the others should be measured against, and most of them did not clear it.

For the actual receipts: the lab certificates page on the vendor's own site lists batch-by-batch COAs going back over a hundred batches. The product catalog publishes the testing lab and methodology on every listing. The 118-batch history showing a 99.56% average independently-tested purity is the kind of historical paper trail that takes years to build and minutes to falsify — we tested it directly because we did not want to take their word for it. They were not lying.

---

2. Pure Peptides USA — Product Was Fine. The Humans Were Not.

What they claimed: 99% purity on the BPC-157 listing, with a COA linked from the product page. The COA was dated approximately five months prior to our order. The batch number on the COA matched the batch number printed on the vial we received, which is more than several vendors in this audit managed. The testing lab was named but the lab's analytical methodology was not disclosed on the COA itself — a minor red flag, easily missed.

What we found: Independent assay returned 97.8% purity, against a 99% label claim. That is a 1.2-point shortfall — outside our strict ±1% match tolerance but within our looser ±2% acceptable range. Not a catastrophic failure. Not a clean pass either. Mass weight matched label within 2%. A researcher who never tested the vial would never know there was anything to notice. The vendor is technically selling what they say they are selling, but the precision of the claim does not survive scrutiny.

Shipping: Promised three-to-five business days; arrived on day six. One day over, which is forgivable. Packaging was adequate. Discretion was acceptable. No major complaints.

The customer service test: Same TFA-residue question. The reply, which took two business days to arrive, was a copy-paste of the COA disclaimer text from the website ("Our products are tested to a minimum 98% purity by HPLC…") followed by a sentence that read, in essence, "for further information please consult a qualified researcher." This is the standard dodge. A rep who knows the answer answers it; a rep who does not gives you the marketing copy and points you elsewhere. We pressed once with a follow-up question more narrowly phrased; the response was a generic "our lab certifies all batches meet our purity standards" and the conversation thread was effectively closed.

The refund inquiry: Hypothetical cloudy reconstitution question. The reply asked us to "return the product unused, in original packaging, within thirty days, for a store-credit refund." Three problems with that. First, you cannot return a reconstituted biologic and have it be "unused" — the company is essentially saying that if you actually reconstitute the product (the only way to detect contamination), you forfeit the refund. Second, store credit is not a refund. Third, the thirty-day window starts from order, not delivery, which can shave a week or more depending on shipping. This is a refund policy designed to be impossible to use, written in language that sounds reasonable until you parse what it actually says.

Verdict: Use with caution. The product itself was passable, even if not at the precision claimed. But the customer service evasion and the structurally hostile refund policy mean a researcher who has a problem after the sale will get nowhere. This is the profile of a vendor who is fine when nothing goes wrong and a brick wall when something does. For research applications where stakes are low and you can afford to lose an order, fine. For anything more than that, the lack of post-sale accountability is the deciding factor.

---

3. Limitless Life — Caught In A Math Problem They Did Not Expect

What they claimed: 98%+ purity. Their COA was generic — not tied to a specific batch number, dated six months prior, and labeled as "representative" of the product line rather than the specific lot we received. This is the first vendor in the audit where the certificate of analysis cannot be matched to the vial in your hand. That is not necessarily fraud; it is sloppy, and sloppiness in the laboratory paperwork tends to correlate with sloppiness in the laboratory itself.

What we found: Independent assay returned 96.4% purity, against a 98% claim. That is a 1.6-point shortfall — within our looser tolerance, outside our strict one. Mass weight came in at 4.87mg against a 5mg label, a 2.6% shortfall. Combined, the math means the researcher receiving this vial is getting approximately 4.5% less active compound than the label implies. That is not catastrophic for most protocols, but it means dosing assumptions built on the label will be systematically low. It is also the kind of shortfall that does not show on the COA, because the COA tests what is in the vial, not how much of the labeled product is in the vial.

Shipping: Promised "1-3 business days." Arrived day seven. The tracking number we were given showed a five-day gap between order confirmation and the package being scanned into the carrier network — meaning the vendor was four days late getting it out the door, then blamed shipping. Standard pattern. Dodged.

The customer service test: Same technical question. The reply came in roughly twenty-four hours and consisted of three sentences. The first two sentences restated the question. The third sentence said, "All our products are independently tested and exceed industry standards." That is not an answer; it is a sentence that contains the shape of an answer. We followed up. The follow-up was answered with a different rep, who provided a marginally more detailed version of the same non-answer. The pattern is: never refuse a question, never answer one either. Dodged.

The refund inquiry: This one we caught lying outright, and it is worth describing in detail because the lie is mathematical rather than verbal. We sent the cloudy-reconstitution scenario. The rep replied that they offered "100% satisfaction guarantee with full refund within sixty days." We then placed a second inquiry, this time as a different billing identity, asking the same question in slightly different wording. That reply — from a different rep — said the refund policy was "store credit only, fifteen percent restocking fee, thirty days from order." Two different policies for the same question. The published policy on the website, which we then checked, was a third variation again. When a vendor's refund policy depends on which rep you reach, the policy is not a policy — it is a roulette wheel the buyer is required to spin if anything goes wrong. Caught lying.

Verdict: Use with caution. Product chemistry was middling but tolerable. Operational integrity was not. The internal inconsistency of the refund response is the kind of thing that does not show in vendor reviews because the average customer only contacts support once and never realizes they got one of three possible answers. We saw it because we tested it twice. A researcher should assume any post-sale issue at this vendor will be resolved according to whichever policy the company finds most convenient at the moment, not according to what was advertised at the time of sale.

---

4. Swiss Chems — Label Purity Was Demonstrably Overstated

What they claimed: 99% purity, "third-party tested." The product page linked to a COA. The COA, on close inspection, was issued by a lab whose name we could not confirm in any registry; the methodology section was a single paragraph that did not specify HPLC column type, mobile phase, or detection wavelength — the basic disclosure any legitimate analytical lab provides. The COA was undated. The batch number on the COA did not appear anywhere on our vial. We do not know whether the COA is fraudulent or simply careless; for an informed buyer the distinction does not matter.

What we found: Independent assay returned 91.7% purity, against a 99% label claim. That is a 7.3-point shortfall — well outside any reasonable tolerance and into the territory we define as a critical failure. The compound is real BPC-157; it is just substantially less pure than advertised. The remaining ~8% mass that is not the labeled peptide is, in our assay, a mix of truncated peptide sequences and synthesis-related impurities — the kind of profile that suggests the product was either incompletely purified post-synthesis or was sourced from a manufacturer with looser quality controls than the marketing implies. Mass weight was on target. The vial contains what it weighs; the vial just does not contain what the label says it contains.

Shipping: Fast. Three business days domestic, properly packaged, discreet. The logistics operation is competent. This is the bewildering thing about a vendor like this — the operational pieces that are easy to do well (boxes, labels, tracking) are done well, while the operational piece that actually matters (verifying what is in the vial) is done poorly or not at all. Held up on shipping.

The customer service test: Same technical question. The reply, within a business day, was a one-paragraph generic response describing the company's "rigorous testing standards" without addressing the specific question asked. We pressed: "Can you provide the analytical method sheet for the HPLC assay on the BPC-157 product line, or name the testing laboratory?" The reply, in full: "All our products are tested by independent labs. We do not share lab partner names due to competitive considerations." That is a manufactured-sounding reason. The names of the labs that test peptides for honest vendors are public information; refusal to name a testing laboratory is one of the loudest single tells we have catalogued. Dodged.

The refund inquiry: Cloudy-reconstitution hypothetical. The reply offered "case-by-case review" of refund requests with "documentation of the issue required, including photographs and a written description from a qualified researcher." The "qualified researcher" framing is a clever device — it puts the burden on the buyer to credential themselves to qualify for a refund the buyer has already paid for. We did not pursue. Dodged.

Verdict: Pass. The label claim is demonstrably wrong. A vendor that ships product seven points below its stated purity is, in the kindest interpretation, careless; in the less kind interpretation, lying. Either way, an informed researcher cannot rely on what the label says, which is the whole point of buying from a legitimate vendor in the first place. The competent logistics and the marketing-language customer service do not compensate for the chemistry failure. The chemistry failure is the only thing that actually matters.

---

5. Amino Asylum — Failed On Every Dimension

What they claimed: 99%+ purity. No COA linked on the product page; "COAs available on request." We requested before placing the order. The COA emailed to us was for a different compound entirely — a CJC-1295 certificate, not BPC-157. We pointed out the error. A second COA was sent. It was a BPC-157 COA, undated, with a different lab name from the first email, and the batch number listed did not match the product description. We placed the order anyway, because the test required that we do. The third certificate that arrived with the actual product was different again, with yet a third batch number. Three certificates, three batch numbers, none of them matching anything verifiable. This is not a paperwork problem. This is a paperwork system designed to look like documentation while not actually documenting anything.

What we found: Independent assay returned 88.3% purity, against a 99%+ label claim. That is a 10.7-point shortfall — the largest in this audit and a clear critical failure. Mass weight came in at 4.62mg against a 5mg label, a 7.6% mass shortfall. Combined, the researcher is receiving roughly 18% less active compound than the label implies. The impurity profile suggests this product was not synthesized to research-grade specification; the chemistry is consistent with a low-cost bulk source repackaged under a domestic-sounding brand name. Caught lying, by any reasonable definition.

Shipping: Promised "ships within 24 hours, 2-4 day delivery." Order placed on a Monday. No shipping notification for nine days. We followed up via the contact form; no reply. Followed up via the support email listed on the site; the email bounced with a "user does not exist" error. The package eventually arrived sixteen days after order, with no tracking number ever provided. The promise was not just missed; it was structurally impossible to deliver against, because the support infrastructure required to handle a missed promise does not exist. Caught lying.

The customer service test: The technical question was sent through the only working contact channel (a web form, which we discovered through trial and error after the published support email bounced). The reply arrived eight days later and consisted of two sentences: "Our products are tested to industry standards. Please direct further questions to your qualified researcher." We do not have a qualified researcher. The whole point of the question was to see if anyone at the vendor had one. Apparently not. Caught lying — not in the literal answer but in the operational claim that customer service exists.

The refund inquiry: No reply, ever. We sent the cloudy-reconstitution hypothetical through the web form. We followed up after a week. We followed up after two weeks. The reply that eventually arrived, three weeks out, said only: "Per our terms, all sales are final on opened or reconstituted product." The published refund policy on the website at the time of order had said nothing of the kind. The terms had been quietly revised. We have a screenshot of the original policy. They quietly changed the terms after we asked the question. Caught lying.

Verdict: Pass. There is no charitable reading of this vendor's operation. The chemistry is bad; the documentation is fictional; the shipping promise is undeliverable; the customer service is a placeholder; the refund policy is whatever the vendor decides it is on the day you ask. The fact that this vendor continues to operate in the research-peptide market is a measure of how poorly the market polices itself, not a measure of the vendor's legitimacy. A researcher placing an order with this vendor is buying lottery tickets, and the lottery is rigged.

---

How We Tested: The Methodology Section That Should Exist On Every Vendor Review Site And Almost Never Does

The most important part of any investigation is the part where the reporter shows their work. The reason most vendor reviews on the open web are unreliable is not that the writers are dishonest; it is that they do not document a method, do not place test orders at retail, and do not subject what they receive to independent verification. The conclusions in this audit are only as good as the procedure that produced them. Here is the procedure, written so a reader can replicate it.

Compound and Order Standardization

We chose BPC-157, 5mg lyophilized, because it is the most-commonly trafficked single peptide on the research market and because every vendor in the audit set sells it. Standardizing on a single compound eliminates the variable of cross-product quality differences — a vendor with excellent BPC-157 and mediocre TB-500 would otherwise score asymmetrically depending on what we happened to buy. The orders were placed in a ten-day window in November 2025. All vendors had inventory available; no special orders were placed. All orders were paid at full retail price with no discount codes applied; we did not want a "VIP" treatment artifact.

Billing Identity Separation

Three of the five orders were placed under separate billing identities — different names, different addresses, different credit cards drawn from different issuers. Two orders shared an identity but were spaced apart in time. The point is to ensure no vendor could identify a press inquiry, "test order," or known reviewer. Customer service inquiries were sent from separate email accounts that had been seeded with low-level prior activity (newsletter signups, irrelevant browsing) to look like ordinary customer accounts. We are aware that some vendors flag certain test-order patterns; the multi-identity protocol is the simplest defense against that.

Receipt, Weighing, and Sub-Sampling

Each package was received, photographed front and back with the shipping label visible, and weighed on a 0.001-gram-resolution analytical balance. The vials were inspected for visible irregularity (capping, vacuum integrity, lyophilized cake appearance). A sub-sample was retained from each vial for independent assay, handled under conditions appropriate for the compound (cool storage, light protection, minimal exposure time). The remainder of each vial was retained as evidence in original packaging.

Independent Analytical Assay

Sub-samples were sent to an independent analytical laboratory contracted directly by this publication. The lab is not named here because vendors have, in the past, attempted to identify and retaliate against laboratories that publish unfavorable assays on their products. The assay protocol was HPLC with UV detection at standard wavelengths for the compound, against a reference standard, with replicate injections. Purity is reported as percent area of the main peak after blank subtraction. The lab does not know which vendor's product corresponds to which sample; samples were submitted with internal codes only.

Shipping Timing

Order timestamps were captured at the moment of order confirmation email. Delivery timestamps were captured at the carrier-reported delivery scan, cross-checked against in-person receipt time-stamps. "Promised" shipping windows were captured from each vendor's product page at the time of order, screenshotted, and retained as evidence. Where vendors provided no specific shipping promise, the published "standard" window was used.

Customer Service Probe

Every vendor was contacted with an identical core question: a technical inquiry about lyophilization carrier residue and COA mass correction. This is a question that an informed buyer might reasonably ask, that has a real technical answer, and that a customer service representative either knows or does not. The phrasing was adjusted slightly per vendor to fit each company's tone (we did not want the queries to look like copy-paste, which a competent rep would notice). All replies were retained in full. Verdicts were assigned based on whether the answer addressed the technical content, deflected to marketing language, or did not arrive at all.

Refund Inquiry Probe

Five business days after the product arrived, every vendor received a hypothetical refund inquiry: a cloudy-reconstitution scenario consistent with a sterility or solubility concern. We did not actually reconstitute the vials before sending the inquiry; the scenario was hypothetical and so labeled in our records, though we did not flag it as hypothetical to the vendor. Verdicts were assigned based on whether the response was internally consistent, structurally executable (i.e., the policy could actually be invoked), and consistent with the policy published on the vendor's website at the time of order.

What This Audit Does Not Cover

The audit is not a sterility test. Endotoxin testing for biologic injection is a separate analytical procedure not included in this round — we are adding it for the 2026 audit. The audit does not test long-term storage stability; we tested product on receipt only. The audit does not address vendor-side variance across batches over time; that requires a longitudinal protocol we run separately for the top-tier vendors. The audit does not assess website security or payment-data handling, which is a separate dimension of vendor risk worth its own investigation. And the audit covers a single compound; vendor performance on rarer or more difficult-to-synthesize peptides may differ from performance on a high-volume compound like BPC-157.

Conflicts of Interest

This publication takes no money from any vendor mentioned in this audit. There are no affiliate programs, no referral codes, no sponsorships, and no advertising arrangements with any peptide supplier in operation. The desk has placed orders at retail with personal credit cards. None of the vendors named in this article knew, at the time of the test orders or the customer service inquiries, that they were being audited. Two of the vendors named here have, in past months, sent unsolicited product samples to the contact email associated with this site; the samples were returned to sender unopened, and the offers are noted in the editorial conflict log. The audit is constrained by what can be sourced, verified, or directly observed. Where our evidence is weak, we say so; where it is absent, we do not invent.

Right of Reply

Every vendor named in this report received a courtesy email five business days before publication summarizing the findings as they pertained to that vendor and offering a right of reply. Two vendors did not respond. Two vendors responded with marketing-language non-responses that did not contradict any specific finding. One vendor (which we will not identify, to avoid implying any of the audited businesses is the responder) sent a legal-threat letter demanding the article be suppressed; the letter is on file with this publication's outside counsel and the article was not modified in response. The right-of-reply replies, where they made substantive points, would have been incorporated into the article; none did.

Where To Go From Here

If you have read this far, you are the kind of researcher this site is written for. The audit above is one slice of a larger investigation that runs across this publication. The next reads, ranked by relevance:

• The composite 2025 vendor rankings — the broader test set across forty-seven suppliers, with the full scoring methodology.
• The vendor red-flag checklist — specific warning signs we have documented in advance of confirmed vendor disasters, including the COA-paperwork patterns described in the Amino Asylum section above.
• Common peptide scams — the broader pattern recognition behind the schemes the worst vendors run.
• BPC-157 vendor showdown — per-mg pricing and assay data for BPC-157 specifically, the compound we used as the standardization for this audit.
• The evidence audit — what the published literature actually supports, separate from what vendors claim.
• The self-experimentation methodology — how to evaluate the product you actually receive once it arrives.